N-Methyl-D-Aspartate (NMDA) Receptors: Therapeutic Target against Cancer
<p>Glutamate mainly acts as an excitatory neurotransmitter in the central nervous system controlling variety of neuro-physiological functions like synaptic signaling, learning, memory, etc. However, uncontrolled or excessive production of glutamate is neurotoxic and can damage neurons by over...
Saved in:
Main Authors: | Raj Kumar Koiri (Author), Aditi Mehrotra (Author) |
---|---|
Format: | Book |
Published: |
International Journal of Immunotherapy and Cancer Research - Peertechz Publications,
2015-09-03.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An experimental study targeting N-methyl-D-aspartate receptor in depression; beyond ketamine
by: Salim Sheikh, et al.
Published: (2020) -
Enzymes Regulating the Homeostasis of Agonists and Antagonists of the N-Methyl D-Aspartate Receptors
Published: (2019) -
Matricellular Receptors as Potential Targets in Anti-Cancer Therapeutic Strategies
by: Herve Emonard
Published: (2016) -
Effects of N-(2-propylpentanoyl) urea on nmda receptor subtype NR1A/NR2B Expressed in xenopus laevis oocytes
by: Penphimon Ponsup
Published: (2012) -
Targeted delivery of therapeutic oligonucleotides in pancreatic cancer
by: Iris Yang
Published: (2022)